These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15364609)

  • 21. Stem cells and their potential in cell-based cardiac therapies.
    Christoforou N; Gearhart JD
    Prog Cardiovasc Dis; 2007; 49(6):396-413. PubMed ID: 17498520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cell therapy and arrhythmias: state of the art].
    Mattioli AV
    G Ital Cardiol (Rome); 2008 Apr; 9(4):251-61. PubMed ID: 18543794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene therapy for cardiac arrhythmias: a dream soon to come true?
    Donahue JK
    J Cardiovasc Electrophysiol; 2007 May; 18(5):553-9. PubMed ID: 17456137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stem cells in cardiovascular disease: methods and protocols.
    Penn MS; Mal N
    Methods Mol Med; 2006; 129():329-51. PubMed ID: 17085822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stimulation of paracrine pathways with growth factors enhances embryonic stem cell engraftment and host-specific differentiation in the heart after ischemic myocardial injury.
    Kofidis T; de Bruin JL; Yamane T; Tanaka M; Lebl DR; Swijnenburg RJ; Weissman IL; Robbins RC
    Circulation; 2005 May; 111(19):2486-93. PubMed ID: 15883216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular endothelial growth factor-expressing mesenchymal stem cell transplantation for the treatment of acute myocardial infarction.
    Matsumoto R; Omura T; Yoshiyama M; Hayashi T; Inamoto S; Koh KR; Ohta K; Izumi Y; Nakamura Y; Akioka K; Kitaura Y; Takeuchi K; Yoshikawa J
    Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1168-73. PubMed ID: 15831811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The past, present, and future of pacemaker therapies.
    Boink GJ; Christoffels VM; Robinson RB; Tan HL
    Trends Cardiovasc Med; 2015 Nov; 25(8):661-73. PubMed ID: 26001958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A balancing act: therapeutic approaches for the modulation of angiogenesis.
    Springer ML
    Curr Opin Investig Drugs; 2006 Mar; 7(3):243-50. PubMed ID: 16555684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Device management of arrhythmias after Fontan conversion.
    Tsao S; Deal BJ; Backer CL; Ward K; Franklin WH; Mavroudis C
    J Thorac Cardiovasc Surg; 2009 Oct; 138(4):937-40. PubMed ID: 19660377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stem cell-based biological pacemakers from proof of principle to therapy: a review.
    Chauveau S; Brink PR; Cohen IS
    Cytotherapy; 2014 Jul; 16(7):873-80. PubMed ID: 24831844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell and gene therapy strategies for the treatment of postmyocardial infarction ventricular arrhythmias.
    Gepstein L
    Ann N Y Acad Sci; 2010 Feb; 1188():32-8. PubMed ID: 20201883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene therapy for restoring heart rhythm.
    Boink GJ; Robinson RB
    J Cardiovasc Pharmacol Ther; 2014 Sep; 19(5):426-38. PubMed ID: 24742766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural and electrical remodeling as therapeutic targets in heart failure.
    Cutler MJ; Rosenbaum DS; Dunlap ME
    J Electrocardiol; 2007; 40(6 Suppl):S1-7. PubMed ID: 17993305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell therapy with autologous bone marrow mononuclear stem cells is associated with superior cardiac recovery compared with use of nonmodified mesenchymal stem cells in a canine model of chronic myocardial infarction.
    Mathieu M; Bartunek J; El Oumeiri B; Touihri K; Hadad I; Thoma P; Metens T; da Costa AM; Mahmoudabady M; Egrise D; Blocklet D; Mazouz N; Naeije R; Heyndrickx G; McEntee K
    J Thorac Cardiovasc Surg; 2009 Sep; 138(3):646-53. PubMed ID: 19698851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene therapy for cardiac arrhythmias.
    Donahue JK; Kikuchi K; Sasano T
    Trends Cardiovasc Med; 2005 Aug; 15(6):219-24. PubMed ID: 16182132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic prospects of cardiac gene transfer.
    Kizana E
    Heart Lung Circ; 2007 Jun; 16(3):180-4. PubMed ID: 17446126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transplantation of adipose-derived stem cells overexpressing hHGF into cardiac tissue.
    Zhu XY; Zhang XZ; Xu L; Zhong XY; Ding Q; Chen YX
    Biochem Biophys Res Commun; 2009 Feb; 379(4):1084-90. PubMed ID: 19146824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. S100A1 gene therapy preserves in vivo cardiac function after myocardial infarction.
    Pleger ST; Remppis A; Heidt B; Völkers M; Chuprun JK; Kuhn M; Zhou RH; Gao E; Szabo G; Weichenhan D; Müller OJ; Eckhart AD; Katus HA; Koch WJ; Most P
    Mol Ther; 2005 Dec; 12(6):1120-9. PubMed ID: 16168714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular endothelial growth factor expressing mesenchymal stem cells improves cardiac function in chronic myocardial infarction in pigs.
    Yi F; Guo WY; Lü AL; Wang HC; Li H; Li WJ; Liu B; Zhang DX; Luan RH; Cheng HX; Li F; Qin T; Zhao ZJ; Gao F; Jia GL
    Chin Med J (Engl); 2006 Oct; 119(19):1664-8. PubMed ID: 17042980
    [No Abstract]   [Full Text] [Related]  

  • 40. [Research progress in cardiac biological pacemaker created by cell transplantation].
    Fu Y; Yu F; Liao B
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Sep; 22(9):1135-8. PubMed ID: 18822746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.